Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Diabetes

Glycaemia and insulin after acute myocardial infarction

Nature Reviews Endocrinology volume 10, pages 448–450 (2014)Cite this article

Subjects

The long-term outcomes of the DIGAMI 1 study indicate that intensive glucose lowering could be beneficial after an acute myocardial infarction in patients with type 2 diabetes mellitus. However, questions have been raised about whether it is acute or long-term glycaemic control or insulin that is beneficial.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Ritsinger, V. et al. Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial. Lancet Diabetes Endocrinol. http://dx.doi.org/10.1016/S2213-8587(14)70088-9.

  2. Cheung, N. W., Wong, V. W. & McLean, M. The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care 29, 765–770 (2006).

    Article  CAS  Google Scholar 

  3. Krljanac, G. et al. Effects of glucose–insulin–potassium infusion on ST-elevation myocardial infarction in patients treated with thrombolytic therapy. Am. J. Cardiol. 96, 1053–1058 (2005).

    Article  CAS  Google Scholar 

  4. Chaudhuri, A. et al. Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction. Circulation 109, 849–854 (2004).

    Article  CAS  Google Scholar 

  5. Marfella, R. et al. Tight glycemic control reduces heart inflammation and remodeling during acute myocardial infarction in hyperglycemic patients. J. Am. Coll. Cardiol. 53, 1425–1436 (2009).

    Article  CAS  Google Scholar 

  6. Mehta, S. R. et al. Effect of glucose–insulin–potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE–ECLA randomized controlled trial. JAMA 293, 437–446 (2005).

    Article  Google Scholar 

  7. Selker, H. P. et al. Out-of-hospital administration of intravenous glucose–insulin–potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial. JAMA 307, 1925–1933 (2012).

    Article  CAS  Google Scholar 

  8. de Mulder, M. et al. Intensive glucose regulation in hyperglycemic acute coronary syndrome: results of the randomized BIOMarker study to identify the acute risk of a coronary syndrome-2 (BIOMArCS-2) glucose trial. JAMA Intern. Med. 173, 1896–1904 (2013).

    Article  CAS  Google Scholar 

  9. Dandona, P. & Boden, W. E. Intensive glucose control in hyperglycemic patients with acute coronary syndromes: still smoke, but no fire. JAMA Intern. Med. 173, 1905–1906 (2013).

    Article  Google Scholar 

  10. Kosiborod, M. et al. Glucose normalization and outcomes in patients with acute myocardial infarction. Arch. Intern. Med. 169, 438–446 (2009).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Endocrinology, State University of New York at Buffalo, Diabetes and Metabolism, Buffalo, 14221, NY, USA

    Paresh Dandona & Ajay Chaudhuri

Authors
  1. Paresh Dandona
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ajay Chaudhuri
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paresh Dandona.

Ethics declarations

Competing interests

P.D. and A.C. have been speakers for Lilly, Novo-Nordisk and Sanofi-Aventis.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dandona, P., Chaudhuri, A. Glycaemia and insulin after acute myocardial infarction. Nat Rev Endocrinol 10, 448–450 (2014). https://doi.org/10.1038/nrendo.2014.101

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrendo.2014.101

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing